Structural Biology in Drug Discovery

 Rational drug design aims to develop small molecules (drugs) with a therapeutic effect by targeting biomolecules in order to influence their biological function. Structural biology has a diverse arsenal of methods available to study (bio) molecular structures. Information on the shape and possible interaction sites of binding sites on these molecules can be used to design small molecules with high binding affinity. The structural information is a valuable input in different stages of drug development such as lead optimization or drug design. Important starting point in rational drug design is that Structural determination of bio molecules could help as therapeutic target. Soon after knowing the structure of biological target, an impending binding site for drugs and its interactions have to be identified in the period of drug design

 

  • 8-1. Cancer drug design and discovery
  • 8-2. Molecular modeling in drug design
  • 8-3. Transformative concepts for drug design
  • 8-4. Molecular basis of drug design
  • 8-5. Frontiers in drug design and drug discovery
  • 8-6. Protein crystallography in drug discovery
  • 8-7. Fragment based drug design
  • 8-8. Drug design strategies

Related Conference of Structural Biology in Drug Discovery

May 19-20, 2025

8th Global Conference on Cell and Gene Therapy

Singapore City, Singapore
June 16-17, 2025

21st Global Summit on Stem Cell & Regenerative Medicine

Frankfurt, Germany
July 21-22, 2025

18th World Congress on Stem Cell Research

Barcelona, Spain

Structural Biology in Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in